SANDERS MACHELLE
SEC CIK 1718020 · EDGAR
BoughtSold
Most active insiders at FTRE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Thakral Anshul | CEO, Dir | — | $3.94M |
| 2 | Morais Mark A. | COO | — | $370.7K |
| 3 | SANDERS MACHELLE | Dir | — | $174.7K |
| 4 | Mcconnell Jill G. | CFO | — | $150.1K |
| 5 | Parks Robert | CAO | — | $44.4K |
| 6 | Russell Carrie Elizabeth | Interim CAO | — | $4,145 |
| 7 | Ray Amrit | Dir | — | — |
| 8 | Smith David Ross | Dir | — | — |
| 9 | Russell Erin L | Dir | — | — |
| 10 | Pesicka Edward A | Dir | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 16:04 | 2026-08-03 | FTRE | Fortrea Holdings Inc. | SANDERS MACHELLE | Dir | S - Sale | $18.01 | -9,700 | 36.4K | -21% | -$174.7K | |
| D | 2026-06-15 16:14 | 2026-06-11 | BCRX | BIOCRYST PHARMACEUTICALS INC | SANDERS MACHELLE | Dir | A - Grant | $0.00 | +15.3K | 45.9K | +50% | $0 |
| D | 2026-06-12 16:18 | 2026-06-10 | FTRE | Fortrea Holdings Inc. | SANDERS MACHELLE | Dir | M - OptEx | $0.00 | +38.8K | 46.1K | +533% | $0 |
| 2025-11-17 | 2025-11-13 | BCRX | BIOCRYST PHARMACEUTICALS INC | SANDERS MACHELLE | Dir | S - Sale | $7.14 | -9,600 | 30.6K | -24% | -$68.5K | |
| D | 2025-06-16 | 2025-06-12 | BCRX | BIOCRYST PHARMACEUTICALS INC | SANDERS MACHELLE | Dir | A - Grant | $0.00 | +12.5K | 40.2K | +45% | $0 |
| D | 2025-05-16 | 2025-05-14 | FTRE | Fortrea Holdings Inc. | SANDERS MACHELLE | Dir | M - OptEx | $0.00 | +7,282 | 7,282 | New | $0 |
| 2024-06-17 | 2024-06-17 | BCRX | BIOCRYST PHARMACEUTICALS INC | SANDERS MACHELLE | Dir | S - Sale | $6.00 | -4,689 | 27.7K | -14% | -$28.1K | |
| D | 2024-06-14 | 2024-06-12 | BCRX | BIOCRYST PHARMACEUTICALS INC | SANDERS MACHELLE | Dir | A - Grant | $0.00 | +6,820 | 32.4K | +27% | $0 |
| D | 2023-06-15 | 2023-06-13 | BCRX | BIOCRYST PHARMACEUTICALS INC | SANDERS MACHELLE | Dir | A - Grant | $0.00 | +16.7K | 29.6K | +130% | $0 |
| D | 2023-06-15 | 2023-06-15 | BCRX | BIOCRYST PHARMACEUTICALS INC | SANDERS MACHELLE | Dir | S - Sale | $7.98 | -4,000 | 25.6K | -14% | -$31.9K |
| D | 2022-06-09 | 2022-06-07 | BCRX | BIOCRYST PHARMACEUTICALS INC | SANDERS MACHELLE | Dir | A - Grant | $0.00 | +12.9K | 12.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations